Transparency

It is essential that patients have confidence that the relationship between physicians (and other healthcare professionals) and the industry that commercializes medicines are open and transparent.

At Almirall, we fully support and adhere to the EFPIA Transparency Code.

 

2022

2021

 

2022

2021

 

2022

2021

 

2023

2022

 

2023

2022

2021

 

2022

2021

For further information on the EFPIA disclosure code click here

Depending on the countries, disclosures on an individual names basis are subject to appropriate consent and may be revoked at any time by notifying by email to tovconsent@almirall.com.

  • The publication of this data responds to the transparency obligations derived from the Code of Good Practice for the Pharmaceutical Industry.
  • La publicación de estos datos responde a las obligaciones de transparencia derivadas del Código de Buenas Prácticas de la Industria Farmacéutica.
  • The publication of this information does not derive a general authorization for those who access the website to carry out an additional treatment of the professionals’ data, i.e. crossing the professionals’ data with the information published in other partner’s websites.
  • De la publicación de la información no se deriva una habilitación general para quienes accedan al sitio web puedan llevar a cabo un tratamiento adicional de los datos de los profesionales, tales como su cruce con las informaciones publicadas en los sitios web de otros asociados.
  • The laboratory has adopted security levels in order to avoid indexing of the information through search engines.
  • El laboratorio ha adoptado niveles de seguridad para evitar la indexación de la información a través de motores de búsqueda.